SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-18-000271
Filing Date
2018-02-01
Accepted
2018-02-01 17:26:18
Documents
2
Period of Report
2018-01-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gala_8k.htm 8-K 16924
2 CERTIFICATE OF AMENDMENT gala_8k-0301.htm EX-3.1 6801
  Complete submission text file 0001683168-18-000271.txt   25173
Mailing Address 2780 SOUTH JONES BLVD., #3725 LAS VEGAS, NEVADA X1 89146
Business Address 2780 SOUTH JONES BLVD., #3725 LAS VEGAS, NEVADA X1 89146 (702) 900-6074
Gala Pharmaceutical Inc. (Filer) CIK: 0001513403 (see all company filings)

IRS No.: 421771014 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 333-172744 | Film No.: 18567816
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl